Priority 6 from the Sight Loss and Vision PSP Age Related Macular Degeneration

UNCERTAINTY: What is the most effective way to detect and monitor the progression of early AMD? (JLA PSP Priority 6)

Overall ranking 6
JLA question ID 0014a/6
Explanatory note Existing relevant systematic reviews were not up-to-date at the time of the PSP
Evidence Systematic review and economic modelling of optical coherence tomography (OCT) for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration.
Health Research Classification System category Eye
Extra information provided by this PSP
Original uncertainty examples None provided
Systematic reviews that need updating or extending None identified
Systematic reviews in preparation (at time of PSP) None identified
Ongoing controlled trials Genetics and Markers of Degenerative and Inflammatory Eye Diseases NCT00647439
Submitted by Clinicians
Outcomes to be measured Diagnostic; change in symptoms; adverse effects or complications; acceptability to the patient; and cost
PSP information
PSP unique ID 0014a
PSP name Sight Loss and Vision - Age Related Macular Degeneration
Total number of uncertainties identified by this PSP. 113  (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
Date of priority setting workshop April and May 2013